Cargando…
Effectiveness of risk minimization measures for the use of cilostazol in United Kingdom, Spain, Sweden, and Germany
PURPOSE: The purpose of the study is to evaluate the effectiveness of risk minimization measures—labeling changes and communication to health care professionals—recommended by the European Medicines Agency for use of cilostazol for the treatment of intermittent claudication in Europe. METHODS: Obser...
Autores principales: | Castellsague, Jordi, Poblador‐Plou, Beatriz, Giner‐Soriano, Maria, Linder, Marie, Scholle, Oliver, Calingaert, Brian, Bui, Christine, Arana, Alejandro, Laguna, Clara, Gonzalez‐Rubio, Francisca, Roso‐Llorach, Albert, Prados‐Torres, Alexandra, Perez‐Gutthann, Susana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175151/ https://www.ncbi.nlm.nih.gov/pubmed/30043552 http://dx.doi.org/10.1002/pds.4584 |
Ejemplares similares
-
Characterization of new users of cilostazol in the UK, Spain, Sweden, and Germany
por: Castellsague, Jordi, et al.
Publicado: (2017) -
Validity of ICD‐9 and ICD‐10 codes used to identify acute liver injury: A study in three European data sources
por: Forns, Joan, et al.
Publicado: (2019) -
Patterns of use of antimuscarinic drugs to treat overactive bladder in Denmark, Sweden, and the United Kingdom
por: Margulis, Andrea V., et al.
Publicado: (2018) -
Do Centenarians Die Healthier than Younger Elders? A Comparative Epidemiological Study in Spain
por: Clerencia-Sierra, Mercedes, et al.
Publicado: (2020) -
Applying diagnosis and pharmacy-based risk models to predict pharmacy use in Aragon, Spain: The impact of a local calibration
por: Calderón-Larrañaga, Amaia, et al.
Publicado: (2010)